Search research articles
Contact Us
Filters
Showing results (321-330 of 393) with videos related to
Page
of 40
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 4, 2025
Factors Associated with Incomplete Adherence to Dolutegravir-Based Antiretroviral Therapy in Southwestern Uganda
Cameron T Nutt, Winnie R Muyindike, Victoria Nanfuka, et al.
The Journal of Infectious Diseases
|
May 15, 2024
Population Effectiveness of Dolutegravir Implementation in Uganda: A Prospective Observational Cohort Study (DISCO), 48-Week Results
Suzanne M McCluskey, Winnie R Muyindike, Victoria Nanfuka, et al.
Plos One
|
February 9, 2021
Insomnia symptoms and biomarkers of monocyte activation, systemic inflammation, and coagulation in HIV: Veterans Aging Cohort Study
Brittanny M Polanka, Suman Kundu, Kaku A So-Armah, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 19, 2010
Risk factors influencing antibody responses to Kaposi's sarcoma-associated herpesvirus latent and lytic antigens in patients under antiretroviral therapy
Moraima Guadalupe, Brad H Pollock, Steven Westbrook, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
September 25, 2024
Integrated Stepped Alcohol Treatment With Contingency Management for Unhealthy Alcohol Use Among People With HIV: A Randomized Controlled Trial
E Jennifer Edelman, James Dziura, Yanhong Deng, et al.
Annals of Internal Medicine
|
October 26, 2021
Resistance Testing for Management of HIV Virologic Failure in Sub-Saharan Africa : An Unblinded Randomized Controlled Trial
Mark J Siedner, Mahomed-Yunus S Moosa, Suzanne McCluskey, et al.
The Lancet. HIV
|
March 30, 2026
Incident diabetes after switching to integrase strand transfer inhibitors in people with HIV in the USA and Canada: a cohort study
Y Joseph Hwang, Catherine R Lesko, Todd T Brown, et al.
AIDS (London, England)
|
March 20, 2024
Regional variation in weight change after the transition to dolutegravir in Uganda and South Africa
Richard Migisha, Geoffrey Chen, Winnie R Muyindike, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 4, 2022
Five-Year Mortality for Adults Entering Human Immunodeficiency Virus Care Under Universal Early Treatment Compared With the General US Population
Jessie K Edwards, Stephen R Cole, Tiffany L Breger, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 23, 2026
HIV viral non-suppression and drug resistance among persons who inject drugs on dolutegravir antiretroviral therapy in Kenya
Loice W Mbogo, Ceejay L Boyce, Betsy Sambai, et al.
Page
of 40
Search research articles
Search
Showing results (321-330 of 393) with videos related to
Sort By:
Page
of 40
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 4, 2025
Factors Associated with Incomplete Adherence to Dolutegravir-Based Antiretroviral Therapy in Southwestern Uganda
Cameron T Nutt, Winnie R Muyindike, Victoria Nanfuka, et al.
The Journal of Infectious Diseases
|
May 15, 2024
Population Effectiveness of Dolutegravir Implementation in Uganda: A Prospective Observational Cohort Study (DISCO), 48-Week Results
Suzanne M McCluskey, Winnie R Muyindike, Victoria Nanfuka, et al.
Plos One
|
February 9, 2021
Insomnia symptoms and biomarkers of monocyte activation, systemic inflammation, and coagulation in HIV: Veterans Aging Cohort Study
Brittanny M Polanka, Suman Kundu, Kaku A So-Armah, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 19, 2010
Risk factors influencing antibody responses to Kaposi's sarcoma-associated herpesvirus latent and lytic antigens in patients under antiretroviral therapy
Moraima Guadalupe, Brad H Pollock, Steven Westbrook, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
September 25, 2024
Integrated Stepped Alcohol Treatment With Contingency Management for Unhealthy Alcohol Use Among People With HIV: A Randomized Controlled Trial
E Jennifer Edelman, James Dziura, Yanhong Deng, et al.
Annals of Internal Medicine
|
October 26, 2021
Resistance Testing for Management of HIV Virologic Failure in Sub-Saharan Africa : An Unblinded Randomized Controlled Trial
Mark J Siedner, Mahomed-Yunus S Moosa, Suzanne McCluskey, et al.
The Lancet. HIV
|
March 30, 2026
Incident diabetes after switching to integrase strand transfer inhibitors in people with HIV in the USA and Canada: a cohort study
Y Joseph Hwang, Catherine R Lesko, Todd T Brown, et al.
AIDS (London, England)
|
March 20, 2024
Regional variation in weight change after the transition to dolutegravir in Uganda and South Africa
Richard Migisha, Geoffrey Chen, Winnie R Muyindike, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 4, 2022
Five-Year Mortality for Adults Entering Human Immunodeficiency Virus Care Under Universal Early Treatment Compared With the General US Population
Jessie K Edwards, Stephen R Cole, Tiffany L Breger, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 23, 2026
HIV viral non-suppression and drug resistance among persons who inject drugs on dolutegravir antiretroviral therapy in Kenya
Loice W Mbogo, Ceejay L Boyce, Betsy Sambai, et al.
Page
of 40